Skip to Content

Azenta Inc AZTA

Morningstar Rating
$51.08 +0.14 (0.27%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AZTA is trading within a range we consider fairly valued.
Price
$50.86
Fair Value
$15.97
Uncertainty
High
1-Star Price
$45.62
5-Star Price
$51.88
Economic Moat
Dkpkn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AZTA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$50.94
Day Range
$50.8351.71
52-Week Range
$42.4369.16
Bid/Ask
$50.64 / $51.53
Market Cap
$2.75 Bil
Volume/Avg
444,695 / 480,469

Key Statistics

Price/Earnings (Normalized)
119.69
Price/Sales
4.54
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
19.38%

Company Profile

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
3,500

Competitors

Valuation

Metric
AZTA
HPQ
6762
Price/Earnings (Normalized)
119.699.8331.33
Price/Book Value
1.241.71
Price/Sales
4.540.621.39
Price/Cash Flow
56.047.988.97
Price/Earnings
AZTA
HPQ
6762

Financial Strength

Metric
AZTA
HPQ
6762
Quick Ratio
4.810.351.21
Current Ratio
5.860.711.67
Interest Coverage
7.103.77
Quick Ratio
AZTA
HPQ
6762

Profitability

Metric
AZTA
HPQ
6762
Return on Assets (Normalized)
−0.57%9.25%3.73%
Return on Equity (Normalized)
−0.65%7.92%
Return on Invested Capital (Normalized)
−2.14%41.54%5.36%
Return on Assets
AZTA
HPQ
6762
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncMfxjjmtkjtTrhz$143.6 Bil
BDX
Becton Dickinson & CoYpskfvysNxktrm$66.1 Bil
ALC
Alcon IncHnjwsdybMynld$44.4 Bil
RMD
ResMed IncJbyqjrkzlWmfkwjv$31.3 Bil
CLPBY
Coloplast A/S ADRLgxjxwjgmPrzg$28.1 Bil
WST
West Pharmaceutical Services IncTtqkwrtybDrlgh$24.3 Bil
COO
The Cooper Companies IncHwjyvrhzwThbpf$18.2 Bil
BAX
Baxter International IncNzpvfqkCmbsxj$17.3 Bil
HOLX
Hologic IncQwrybwzqXxmddny$17.2 Bil
ATR
AptarGroup IncDvfdzrbwfTmxwz$9.8 Bil

Sponsor Center